Cipla Ltd.
CIPLA · NSE · Healthcare · ₹1,336 a share (close of 05 Oct 2026)
Available company data, source links and archived checks for Cipla Ltd.. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 2.3%; Net profit was ₹785.55 crore.
Quarter ended 2026-06-30 · consolidated · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹7,119 cr | +2.3% | Net profit: ₹786 cr | -39.2% | 11.0% | Company filing source |
| Mar 2026 | Revenue: ₹6,541 cr | -2.8% | Net profit: ₹543 cr | -55.3% | 8.3% | Company filing source |
| Dec 2025 | Revenue: ₹7,074 cr | — | Net profit: ₹674 cr | — | 9.5% | Company filing source |
| Sep 2025 | Revenue: ₹7,589 cr | — | Net profit: ₹1,353 cr | — | 17.8% | Company filing source |
| Jun 2025 | Revenue: ₹6,957 cr | +3.9% | Net profit: ₹1,292 cr | +9.9% | 18.6% | Company filing source |
| Mar 2025 | Revenue: ₹6,730 cr | — | Net profit: ₹1,214 cr | — | 18.0% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
Yusuf Khwaja Hamied 18.7%LICI ULIP-GROWTH FUND 9.8%SOPHIE AHMED 5.7%HDFC TRUSTEE COMPANY LIMITED-HDFC FLEXI CAP FUND 4.5%M K HAMIED 3.5%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- ESOP/ESOS/ESPS. Cipla Limited has informed the Exchange regarding Allotment of 12168 Shares.…
24 Sep 2026 · document
- Change in Management. Cipla Limited has informed the Exchange about change in Senior Management Personnel.…
22 Sep 2026 · document
- General Updates. Intimation under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015…
18 Sep 2026 · document
- Press Release. Cipla Limited has informed the Exchange regarding a press release dated September 03, 2026, titled "Cipla Announces Exclusive Partnership with Qi…
03 Sep 2026 · document
- General Updates. Notice to shareholders and creditors in accordance with NCLT Order dated 18th August, 2026 regarding merger of Inzpera Healthsciences Limited w…
03 Sep 2026 · document
- Copy of Newspaper Publication. Cipla Limited has informed the Exchange about Newspaper Publication regarding opening of special window for re-lodgement of trans…
02 Sep 2026 · document
- Press Release. Cipla Limited has informed the Exchange regarding a press release dated August 31, 2026, titled "Cipla and SBP Group sign exclusive licensing agr…
31 Aug 2026 · document
- General Updates. Cipla Limited has informed the Exchange about Update on USFDA inspection at InvaGen manufacturing facility in Central Islip, Long Island, NY, U…
28 Aug 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time